alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
II 

109TH CONGRESS 

1ST SESSION S. 108 

To prohibit the operation during a calendar year of the final rule issued 

by the Secretary of Agriculture to establish standards for the designation 

of minimal-risk regions for the introduction of bovine spongiform 

encephalopathy into the United States, including designation of Canada 

as a minimal-risk region, and the importation into the United States 

from Canada of certain bovine ruminant products during that calendar 

year, unless country of origin labeling is required for the retail sale 

of a covered commodity during that calendar year. 

IN THE SENATE OF THE UNITED STATES 

JANUARY 24, 2005 

Mr. JOHNSON (for himself, Mr. ENZI, Mr. BINGAMAN, and Mr. DORGAN) introduced the following bill; which was read twice and referred to the Committee on Agriculture, Nutrition, and Forestry 

A BILL 

To prohibit the operation during a calendar year of the 

final rule issued by the Secretary of Agriculture to establish standards for the designation of minimal-risk regions 

for the introduction of bovine spongiform encephalopathy 

into the United States, including designation of Canada 

as a minimal-risk region, and the importation into the 

United States from Canada of certain bovine ruminant 

products during that calendar year, unless country of 

origin labeling is required for the retail sale of a covered 

commodity during that calendar year. 
2 

•S 108 IS

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. ANNUAL CONDITION ON APPLICATION OF 

4 FINAL RULE REGARDING ESTABLISHMENT 

5 OF MINIMAL-RISK REGIONS, INCLUDING CAN6 ADA, FOR BOVINE SPONGIFORM 

7 ENCEPHALOPATHY AND IMPORTATION OF 

8 CERTAIN BOVINE RUMINANT PRODUCTS. 

9 If mandatory country of origin labeling is not re10 quired for the retail sale of a covered commodity during 

11 any calendar year under subtitle D of the Agricultural 

12 Marketing Act of 1946 (7 U.S.C. 1638 et seq.), during 

13 that calendar year— 

14 (1) the final rule issued by the Secretary of Ag15 riculture on January 4, 2005, amending parts 93, 

16 94, 95, and 96 of title 9 of the Code of Federal Reg17 ulations to establish standards for the designation of 

18 minimal-risk regions for the introduction of bovine 

19 spongiform encephalopathy into the United States, 

20 to provide for the importation of certain ruminants, 

21 ruminant products, and ruminant byproducts from 

22 such minimal-risk regions, and to designate Canada 

23 as a minimal-risk region (and any successor regula24 tions) shall not apply; and 
3 

•S 108 IS

1 (2) any bovine ruminant product that (as of the 

2 date of enactment of this Act) was permitted to be 

3 imported into the United States from Canada, may 

4 not be imported into the United States from Can5 ada. 

Æ
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute of Mental Health Special Emphasis Panel, HIV AIDS Training.                    

*Date:*                         March 1, 2010.                    

*Time:*                         10 a.m. to 12 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852. (Telephone Conference Call.)                    

*Contact Person:*                         Enid Light, PhD, Scientific Review Officer, Division of Extramural Activities, National Institute of Mental Health, NIH, Neuroscience Center, 6001 Executive Boulevard, Room 6132, MSC 9608, Bethesda, MD 20852-9608, 301-443-0322,                         *elight@mail.nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.242, Mental Health Research Grants; 93.281, Scientist Development Award, Scientist Development Award for Clinicians, and Research Scientist Award; 93.282, Mental Health National Research Service Awards for Research Training, National Institutes of Health, HHS)

Dated: February 16, 2010.

Jennifer Spaeth,

Director, Office of Federal Advisory Committee Policy.

[FR Doc. 2010-3571 Filed 2-23-10; 8:45 am]

BILLING CODE 4140-01-P
[No. 20479-7-II.

Division Two.

October 31, 1997.]

#### *In the Matter of the Marriage of*Lynn Larson-Sweerus, *Respondent,*and Neil Gordon Sweerus, *Appellant.*

Appeal from a judgment of the Superior Court for Thurston County, No. 95-3-00979-5, Wm. Thomas McPhee, J., entered February 20, 1996. *Affirmed*by unpublished opinion per Hunt, J., concurred in by Houghton, C.J., and Bridgewater, J.
Editorial Note on Part 172
Editorial Note: Nomenclature changes to part 172 appear at 61 FR 14482, Apr. 2, 1996; 66 FR 56035, Nov. 6, 2001; 66 FR 66742, Dec. 27, 2001; 68 FR 15355, Mar. 31, 2003; 70 FR 40880, July 15, 2005; 70 FR 67651, Nov. 8, 2005; 70 FR 72074, Dec. 1, 2005; and 81 FR 49896, July 29, 2016.

§ 172.155 Natamycin (pimaricin). ( a ) Natamycin (CAS Reg. No. 7681-93-8), also known as pimaricin, is a polyene macrolide antimycotic substance possessing an empirical formula of C33H47NO13 and a molecular weight of 665.7.
( b ) The additive shall conform to the following specifications: Purity: 97 percent ±2 percent on an anhydrous basis. Arsenic: Not more than 1 part per million. Heavy metals (as Pb): Not more than 20 parts per million.
( c ) The additive may be applied on cheese, as an antimycotic, in amounts not to exceed 20 milligrams per kilogram (20 parts per million) in the finished product as determined by International Dairy Federation (IDF) Standard 140A:1992, “Cheese and Cheese Rind-Determination of Natamycin Content-Method by Molecular Absorption Spectrometry and by High-Performance Liquid Chromatography,” which is incorporated by reference. The Director of the Office of the Federal Register approves this incorporation by reference in accordance with 5 U.S.C. 552(a) and 1 CFR part 51. Copies are available from the Office of Food Additive Safety (HFS-200), Center for Food Safety and Applied Nutrition, Food and Drug Administration, 5001 Campus Dr., College Park, MD 20740, 240-402-1200, or may be examined at the Dockets Management Staff (HFA-305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852, 240-402-7500, between 9 a.m. and 4 p.m., Monday through Friday, or at the National Archives and Records Administration (NARA). For information on the availability of this material at NARA, call 202-741-6030, or go to: *http://www.archives.gov/federal_register/code_of_federal_regulations/ibr_locations.html .*
[47 FR 26823, June 22, 1982, as amended at 50 FR 49536, Dec. 3, 1985; 63 FR 66015, Dec. 1, 1998; 66 FR 13847, Mar. 8, 2001; 81 FR 5591, Feb. 3, 2016; 88 FR 17719, Mar. 24, 2023]
[No. 39353-7-I.

Division One.

December 22, 1997.]

#### The State of Washington, *Respondent,*v. Eric H. Deasis, *Appellant.*

Appeal from a judgment of the Superior Court for King County, No. 92-1-05329-0, Janice Niemi, J., entered April 15, 1996. *Affirmed*by unpublished per curiam opinion.
EXHIBIT 32.1
                                                                    ------------

                                  CERTIFICATION
                  PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY
          ACT OF 2002 (SUBSECTIONS (A) AND (B) OF SECTION 1350, CHAPTER
                       63 OF TITLE 18, UNITED STATES CODE)

Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and
(b) of section 1350, chapter 63 of title 18, United States Code), each of the
undersigned officers of National Datacomputer, Inc., a Delaware corporation (the
"Company"), does hereby certify, to such officer's knowledge, that:

The Quarterly Report on Form 10-QSB for the period ended September 30, 2006 (the
"Form 10-QSB") of the Company fully complies with the requirements of Section
13(a) or 15(d) of the Securities Exchange Act of 1934, and the information
contained in the Form 10-QSB fairly presents, in all material respects, the
financial condition and results of operations of the Company.


Dated: November 14, 2006               /s/  William B. Berens
                                       --------------------------------
                                       William B. Berens
                                       President and  Chief Executive Officer

Dated: November 14, 2006               /s/ Bruna Bucacci
                                       -------------------------
                                       Bruna Bucacci
                                       Chief Accounting Officer

A signed original of this written statement required by Section 906 has been
provided to the Company and will be retained by the Company and furnished to the
Securities and Exchange Commission or its staff upon request.
March 21, 2000




Mr. R. G. Reherman
Mr. T. L. Burke
Southern Indiana Gas and Electric Company
20 N.W. Fourth Street
Evansville, Indiana 47741

J. H. Byington, Jr., Esq.
Winthrop, Stimson, Putnam & Roberts
One Battery Park Plaza
New York, New York 10004-1490

Dear Gentlemen:

     SIGCORP, Inc. and Southern Indiana Gas and Electric
Company will each file an Annual Report on Form 10-K for the
fiscal year ended December 31, 1999 ("Form 10-K") before
April 1, 2000 which will be accompanied by certain exhibits.

     We hereby authorize you, or any one of you, to complete
said Forms 10-K and to remedy any deficiencies with respect
to said Forms 10-K by appropriate amendment or amendments;
and we hereby make, constitute and appoint each of you our
true and lawful attorney for each of us and in each of our
names, places and steads, both in our individual capacities
as directors and that of officers of SIGCORP, Inc. and
Southern Indiana Gas and Electric Company, to sign and cause
to be filed with the Securities and Exchange Commission said
Forms 10-K, any appropriate amendment or amendments thereto,
and any exhibits thereto.

     The undersigned, SIGCORP, Inc. and Southern Indiana Gas
and Electric Company, also authorize you and any one of you
to sign said Forms 10-K and any








amendment or amendments thereto on its behalf as attorney-in-
fact  for its respective officers, and to file the  same  as
aforesaid together with exhibits.

                         Very truly yours,

                         SIGCORP, INC. and
                         SOUTHERN INDIANA GAS AND
                         ELECTRIC COMPANY



                         By   s/s R. G. Reherman
                            R. G. Reherman
                            Chairman and CEO, SIGCORP, Inc.
                            Chairman, Southern Indiana Gas
                             & Electric Company



     s/s John M. Dunn            s/s Ronald G. Reherman
     John M. Dunn                Ronald G. Reherman


     s/s  John  D.  Engelbrecht  s/s  Richard  W. Shymanski
     John D. Engelbrecht         Richard W. Shymanski


     s/s Andrew E. Goebel        s/s James S. Vinson
     Andrew E. Goebel            James S. Vinson


     s/s Robert L. Koch II       s/sTimothy L. Burke
     Robert L. Koch II           Timothy L. Burke


     s/s Donald A. Rausch          s/s S. Mark Kerney
     Donald A. Rausch              S. Mark Kerney
<PAGE>   1
 
                                                                      EXHIBIT 21
 
                    C.P. CLARE CORPORATION AND SUBSIDIARIES
 
                              LIST OF SUBSIDIARIES
 
<TABLE>
<CAPTION>
                                                                        PLACE OF
                                SUBSIDIARY                           INCORPORATION
          ------------------------------------------------------  --------------------
          <S>                                                     <C>
          Clare Capital, Inc....................................  New York
          Clare Capital, Inc....................................  Delaware
          Clare Components, Inc.................................  New York
          Clare Components, Inc.................................  Delaware
          Clare Electronics, Inc................................  New York
          Clare Electronics, Inc................................  Delaware
          Clare Instruments, Inc................................  New York
          Clare Instruments, Inc................................  Delaware
          Clare Services, Inc...................................  New York
          Clare Services, Inc...................................  Delaware
          Clare Systems, Inc....................................  New York
          Clare Systems, Inc....................................  Delaware
          Clare Technologies, Inc...............................  New York
          Clare Technologies, Inc...............................  Delaware
          Clare Canada, Ltd.....................................  Ontario, Canada
          Clare France S. A. R. L...............................  France
          C. P. Clare Electronics GmbH..........................  Germany
          C. P. Clare Foreign Sales Corporation.................  U.S. Virgin Islands
          C. P. Clare N.V.......................................  Belgium
          C. P. Clare Engineering N.V...........................  Belgium
          C. P. Clare Mexicana S.A. de C.V......................  Mexico
          Clare Technologies (Taiwan), Inc......................  Taiwan
</TABLE>
Editorial Note on Part 173
Editorial Note: Nomenclature changes to part 173 appear at 61 FR 14482, Apr. 2, 1996; 66 FR 56035, Nov. 6, 2001; 66 FR 66742, Dec. 27, 2001; and 81 FR 49896, July 29, 2016.

§ 173.370 Peroxyacids. Peroxyacids may be safely used in accordance with the following prescribed conditions: ( a ) The additive is a mixture of peroxyacetic acid, octanoic acid, acetic acid, hydrogen peroxide, peroxyoctanoic acid, and 1-hydroxyethylidene-1,1-diphosphonic acid.
( b ) ( 1 ) The additive is used as an antimicrobial agent on meat carcasses, parts, trim, and organs in accordance with current industry practice where the maximum concentration of peroxyacids is 220 parts per million (ppm) as peroxyacetic acid, and the maximum concentration of hydrogen peroxide is 75 ppm.
( 2 ) The additive is used as an antimicrobial agent on poultry carcasses, poultry parts, and organs in accordance with current industry standards of good manufacturing practice (unless precluded by the U.S. Department of Agriculture's standards of identity in 9 CFR part 381, subpart P) where the maximum concentration of peroxyacids is 220 parts per million (ppm) as peroxyacetic acid, the maximum concentration of hydrogen peroxide is 110 ppm, and the maximum concentration of 1-hydroxyethylidene-1,1-diphosphonic acid (HEDP) is 13 ppm.
( c ) The concentrations of peroxyacids and hydrogen peroxide in the additive are determined by a method entitled “Hydrogen Peroxide and Peracid (as Peracetic Acid) Content,” July 26, 2000, developed by Ecolab, Inc., St. Paul, MN, which is incorporated by reference. The concentration of 1-hydroxyethylidene-1,1-diphosphonic acid is determined by a method entitled “Determination of 1-hydroxyethylidene-1,1-diphosphonic acid (HEDP) Peroxyacid/Peroxide-Containing Solutions,” August 21, 2001, developed by Ecolab, Inc., St. Paul, MN, which is incorporated by reference. The Director of the Office of the Federal Register approves these incorporations by reference in accordance with 5 U.S.C. 552(a) and 1 CFR part 51. You may obtain copies of these methods from the Office of Food Additive Safety (HFS-200), Center for Food Safety and Applied Nutrition, Food and Drug Administration, 5001 Campus Dr., College Park, MD 20740, 240-402-1200, or you may examine a copy at the Dockets Management Staff (HFA-305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852, 240-402-7500, between 9 a.m. and 4 p.m., Monday through Friday, or at the National Archives and Records Administration (NARA). For information on the availability of this material at NARA, call 202-741-6030, or go to: *http://www.archives.gov/federal_register/code_of_federal_regulations/ibr_locations.html .*
[65 FR 70660, Nov. 27, 2000, as amended at 66 FR 48208, Sept. 19, 2001; 67 FR 61784, Oct. 2, 2002; 81 FR 5593, Feb. 3, 2016; 88 FR 17724, Mar. 24, 2023]
```

[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 7280 Introduced in House (IH)]

<DOC>

118th CONGRESS
  2d Session
                                H. R. 7280

To require the Inspector General of the Department of Housing and Urban 
  Development to testify before the Congress annually, and for other 
                               purposes.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                            February 7, 2024

  Ms. De La Cruz (for herself, Mr. Barr, Mr. Ogles, Mr. Donalds, Mr. 
 Lawler, Mr. Crenshaw, Mr. Flood, Mr. Meuser, Mr. Huizenga, Mr. Rose, 
Mr. Norman, Mr. Weber of Texas, Mr. McCaul, Mr. Posey, Mr. Loudermilk, 
   Mr. Williams of Texas, Ms. Hageman, Mrs. Wagner, and Ms. Porter) 
 introduced the following bill; which was referred to the Committee on 
                           Financial Services

_______________________________________________________________________

                                 A BILL

 
To require the Inspector General of the Department of Housing and Urban 
  Development to testify before the Congress annually, and for other 
                               purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``HUD Transparency Act of 2024''.

SEC. 2. CONGRESSIONAL TESTIMONY.

    Not later than October 1 of each year, the Inspector General of the 
Department of Housing and Urban Development shall appear before the 
Committee on Financial Services of the House of Representatives and the 
Committee on Banking, Housing, and Urban Affairs of the Senate and 
present testimony on the Office of Inspector General's--
            (1) efforts to detect and prevent fraud, waste, and abuse;
            (2) ability to conduct and supervise audits, 
        investigations, and reviews;
            (3) actions to identify opportunities for the programs of 
        the Department of Housing and Urban Development to progress and 
        succeed; and
            (4) ongoing activities regarding any such additional work, 
        as appropriate.
                                 <all>
```
<PAGE>   1
 
                                                                    EXHIBIT 23.1
 
               CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS
 
We consent to reference to our firm under the caption "Experts" in the
Registration Statement (Form S-3) and related Prospectus of InControl, Inc. for
the registration of 875,000 shares of its common stock and to the incorporation
by reference therein of our report dated January 29, 1997, with respect to the
consolidated financial statements of InControl, Inc. included in its Annual
Report (Form 10-K) for the year ended December 31, 1996, filed with the
Securities and Exchange Commission.
 
                                          ERNST & YOUNG LLP
 
Seattle, Washington
August 26, 1997
## F IRST 

## D ISTRICT 

## C OURT OF 

## A PPEAL 

## S TATE OF 

## F LORIDA

_____________________________
No. 1D 21

- 1417

_____________________________
H ENRY L. M URRAY , Appellant,

v.

S TATE O F F LORIDA , Appellee.

_____________________________

On appeal from the Circuit Court for Alachua County

. James M. Colaw , Judge

. September 15, 2021

P ER C URIAM

.
A FFIRMED

. R AY , J AY , and T ANENBAUM , JJ., concur

.

_____________________________ Not final until disposition of any timely and authorized motion under Fla. R. App. P. 9.330 or 9.331

.

_____________________________2 Henry L. Murray, pro se
, Appellant.

Ashley Moody, Attorney General, Tallahassee
, for Appellee.
Editorial Note on Part 175
Editorial Note: Nomenclature changes to part 175 appear at 61 FR 14482, Apr. 2, 1996; 66 FR 56035, Nov. 6, 2001; and 70 FR 72074, Dec. 1, 2005.

§ 175.365 Vinylidene chloride copolymer coatings for polycarbonate film. Vinylidene chloride copolymer coatings identified in this section and applied on polycarbonate film may be safely used as food-contact surfaces, in accordance with the following prescribed conditions: ( a ) The coating is applied as a continuous film over one or both sides of a base film produced from polycarbonate resins complying with § 177.1580 of this chapter.
( b ) The coatings are prepared from vinylidene chloride copolymers produced by copolymerizing vinylidene chloride with acrylonitrile, methyl acrylate, and acrylic acid. The finished copolymers contain at least 50 weight-percent of polymer units derived from vinyldene chloride.
( c ) Optional adjuvant substances employed in the production of the coatings or added thereto to impart desired properties may include sodium dodecylbenzenesulfonate in addition to substances described in § 174.5(d) of this chapter.
( d ) The coating in the finished form in which it is to contact food, when extracted with the solvent or solvents characterizing the type of food, and under the conditions of time and temperature characterizing the conditions of its intended use as determined from tables 1 and 2 of § 176.170(c) of this chapter, shall yield net chloroform-soluble extractives in each extracting solvent not to exceed 0.5 milligram per square inch of coated surface as determined by the methods described in § 176.170(d) of this chapter. In testing the finished food-contact articles, a separate test sample is to be used for each required extracting solvent.
( e ) Acrylonitrile copolymers identified in this section shall comply with the provisons of § 180.22 of this chapter.